Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

International Research Collaboration Reveals Promising Drug Candidate for Treatment of Blood Cancers

Friday, January 17, 2020

An international research collaboration between the United States and Australia has revealed a promising new drug that could treat highrisk leukemiaToday OncoTartis Inc and Childrens Cancer Institute jointly announced the publication of two research...

Artisan Bio Announces Global Research and Discovery Collaboration Agreement with Takeda to Develop Next-Generation Cell Therapy Products

Thursday, January 16, 2020

Artisan Bio Inc a stealth cell therapy engineering company today announced it has entered into a global research and collaboration agreement with Takeda Pharmaceutical Company Limited Takeda for the discovery development and commercialization of nove...

NuMedii, Inc. Announces Pharmaceutical Discovery Collaboration For Ulcerative Colitis

Thursday, January 16, 2020

NuMedii Inc today announced a new partnership with a drug delivery company to develop new therapeutics for ulcerative colitis The collaboration will bring together NuMediis NM asset for ulcerative colitis and a proprietary delivery technology that en...

Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement

Monday, January 13, 2020

Iovance Biotherapeutics Inc a latestage biotechnology company developing novel T cellbased cancer immunotherapies and Cellectis a clinicalstage biopharmaceutical company focused on developing immunotherapies based on geneedited allogeneic CAR TCells...

Zymeworks Announces Agreement with Pfizer and Initiation of a New Phase 2 Trial Evaluating ZW25 in Combination with Ibrance® (palbociclib)

Monday, January 13, 2020

Zymeworks Inc a clinicalstage biopharmaceutical company developing multifunctional therapeutics today announced the initiation of a Phase trial evaluating ZW combination therapy and an agreement with Pfizer which advances the study Zymeworks HERtarg...

Almirall and WuXi Biologics Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases

Friday, January 10, 2020

Almirall SA and WuXi Biologics have today announced the signing of an agreement Through this collaboration Almirall embarks on its strategy to develop highly innovative biologic products for dermatology diseases including atopic dermatitis

Evotec and Bayer Announce New Alliance Focusing on Drug Discovery for Polycystic Ovary Syndrome With Novel Targets From Celmatix

Friday, January 10, 2020

Evotec SE and Bayer AG today announced the expansion of their partnership in womens health indications with a new fiveyear multitarget collaboration with participation from Celmatix Inc to develop multiple clinical candidates for the treatment of pol...

Schrödinger and Bayer collaborate to co- develop de novo design technology and accelerate drug discovery

Thursday, January 09, 2020

Schrdinger and Bayer today announce a fiveyear technology alliance to develop a de novo comprehensive design solution with the goal of accelerating the discovery of innovative and highquality drugs quality The technology should make it possible to li...

Targovax and IOVaxis Therapeutics Enters Option Agreement for TG Mutant RAS Vaccine License and Clinical Development in China

Thursday, January 09, 2020

Targovax ASA a clinical stage immunooncology company developing oncolytic viruses and cancer vaccines to target hardtotreat solid tumors today announces that it has entered into an exclusive option agreement with IOVaxis Therapeutics of Nantong China...

Curis Announces Option and License Agreement with ImmuNext

Wednesday, January 08, 2020

Curis Inc a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer today announced that it has entered into an option and license agreement to acquire exclusive worldwide rights from ImmuNext Inc ImmuN...